Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19

SARS-CoV-2 is causative agent of COVID-19, which is responsible for severe social and economic disruption globally. Lack of vaccine or antiviral drug with clinical efficacy suggested that drug repurposing approach may provide a quick therapeutic solution to COVID-19. Nonstructural protein-15 (NSP15)...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Biomol Struct Dyn
Hlavní autoři: Chandra, Anshuman, Gurjar, Vaishali, Qamar, Imteyaz, Singh, Nagendra
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7298882/
https://ncbi.nlm.nih.gov/pubmed/32462970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1775127
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky